Updated On: 04 February, 2026 03:18 PM IST | New Delhi | IANS
The next step is to develop targeted treatments, such as with metabolic inhibitors, to make immunotherapy more effective, and eventually enable precision medicine tailored to each patient's tumour, with plans to extend the approach to other cancers, the researchers said

Image for representational purpose only. Photo Courtesy: File pic
Scientists in Australia have mapped the "neighbourhoods" of lung cancer cells and found that cell metabolism plays a key role in determining how patients respond to immunotherapy.
Researchers from the University of Queensland's (UQ) Frazer Institute studied cell interactions at cellular resolution in non-small cell lung carcinoma, the most common form of lung cancer, to better understand why some patients don't respond to immunotherapy treatment, Xinhua news agency reported.